Sarissa Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-12,500
Closed -$2.86M 13
2019
Q2
$2.86M Buy
+12,500
New +$2.86M 0.36% 10